Ocera: Ocera Therapeutics (TZYM) & Its Competitors Critical Survey

Ocera Therapeutics (NASDAQ: TZYM) is one of 49 publicly-traded companies in the "Biopharmaceuticals" industry, but how does it weigh in compared to its rivals? We will compare Ocera Therapeutics to similar businesses based on the strength of its valuation, dividends, risk, profitability, analyst recommendations, institutional ownership and earnings. Profitability This table compares Ocera Therapeutics and [...]